6 studies found for:    8649495 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Bendamustine in Combination With Lenalidomide and Dexamethasone in Refractory or Relapsed Multiple Myeloma
Condition: Myeloma
Interventions: Drug: Bendamustine;   Drug: Lenalidomide;   Drug: Dexamethasone;   Drug: Aspirin;   Drug: Prophylaxis;   Drug: Antibiotic;   Other: Biweekly Follow Up;   Other: Cyclical Follow Up;   Other: Restaging;   Other: Post-Treatment Follow Up
2 Completed Velcade-Melphalan-Prednisone in Older Untreated Multiple Myeloma Patients.
Condition: Multiple Myeloma
Interventions: Drug: Velcade;   Drug: Melphalan;   Drug: Prednisone
3 Recruiting Busulfan and Melphalan Conditioning in Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: BUSULFEX®;   Drug: Alkeran®
4 Completed GEM05 for Patients With Multiple Myeloma Under 65 Years
Condition: Multiple Myeloma
Interventions: Drug: VBMCP/VBAD/Velcade;   Drug: Thalidomide/Dexamethasone;   Drug: Velcade/Thalidomide/Dexamethasone
5 Completed IFM 99-02 Thalidomide in Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Thalidomide;   Drug: Biphosphonates
6 Completed VELCADEXA: Velcade and Dexamethasone in Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: Velcade/Dexamethasone

Indicates status has not been verified in more than two years